Joseph K. Belanoff, Chief Executive Officer, 10% Owner at CORCEPT THERAPEUTICS INC (CORT), sold 10,000 shares at $0.88 ($9K) on 2006-11-17, disclosed to the SEC on 2006-11-21.
Scheduled sale ($9k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.88 | 5,000 | $4K | 50.6% |
| 2 | $0.86 | 5,000 | $4K | 49.4% |
| Total | $0.87 avg | 10,000 | $9K | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |